Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Biosimulation Companies

ID: MRFR/HC/7108-HCR
200 Pages
Satyendra Maurya
Last Updated: February 16, 2025
Biosimulation involves the use of computer-based models to simulate biological processes, drug interactions, and various aspects of physiological systems. It is widely utilized in pharmaceutical research and development to predict the behavior of drugs, study disease mechanisms, and optimize treatment strategies.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Biosimulation Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)7.24%
2024 Market Size$ 2.41 Billion
2025 Market Size$ 2.58 Billion
2035 Market Size$ 5.2 Billion

Key Players

Companies such as Certara
Simulations Plus
Schrodinger
Insilico Medicine
Rhenovia Pharma
Molecular Health
Opportunities
  • Growing Focus on Personalized Medicine
  • Advancements in Computational Technologies
  • Regulatory Support for Innovative Approaches

Top Industry Leaders in the Biosimulation Market

Biosimulation Key Companies
ย 
Latestย Biosimulationย Companies Update:

Simulations Plus acquires Immunetrics: This strengthens Simulations Plus' quantitative systems pharmacology (QSP) expertise and expands its reach in oncology, immunology, and autoimmune diseases.

Certara partners with Infosys: This collaboration aims to integrate Certara's biosimulation software with Infosys' life sciences cloud platform, offering more accessible and scalable modeling solutions.

Thermo Fisher Scientific and Simulia collaborate: This partnership focuses on developing digital twins for bioreactors, allowing for real-time monitoring and optimization of biomanufacturing processes.

Certara unveils SimCyp Pediatric 5.0: This latest version of their popular pharmacokinetic (PK) simulation platform features an expanded pediatric database and new modeling capabilities for pediatric drug development.

Physiomics launches the Virtual Tumor Suite 5.0: This upgraded software offers improved tumor growth and treatment response prediction for personalized medicine applications.

Advanced Chemistry Labs introduces the NMRViewยฎ Exchange software: This innovative tool automates the analysis of biomolecular interactions using nuclear magnetic resonance (NMR) spectroscopy.

List ofย Biosimulationย Key companies in the market
  • Dassault Systรจmes (France)
  • Certaraย USA, Inc. (US)
  • Simulation Plus (US)
  • Schrรถdinger (US)
  • Chemical Computing Group (Canada)
  • Physiomics (UK)
  • In Silico Biosciences (US)
  • Advanced Chemistry Development, Inc. (Canada)
  • Genedata AG (Switzerland)
  • Nuventra Pharma (US)
  • Evidera (US)
  • Leadinvent Technologies (India)
  • LeadScope, Inc. (US)
  • Rosa (US)
  • INOSIM Software GmbH (Germany)

ย